Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Mephenesin carbamate
RN: 533-06-2
UNII: PAD6SXB23N
InChIKey: KRPAJLYSLFNDOA-UHFFFAOYSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C11-H15-N-O4

Molecular Weight

  • 225.242
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Mephenesin carbamate

Synonyms

  • 1,2-Propanediol, 3-(o-tolyloxy)-, 1-carbamate
  • 1,2-Propanediol,3-(o-tolyloxy)-,1-carbamate
  • 1-Carbamoyloxy-2-hydroxy-3-(o-methylphenoxy)propane
  • 2-Hydroxy-3-o-tolyloxypropyl 1-carbamate
  • 3-(2-Methylphenoxy)-1,2-propanediol 1-carbamate
  • 3-o-Toloxy-1,2-propanediol 1-carbamic acid ester
  • 3-o-Toloxy-2-hydroxypropyl 1-carbamate
  • 3-o-Tolyloxy-2-hydroxypropyl 1-carbamate
  • 4-06-00-01954 (Beilstein Handbook Reference)
  • BRN 1880597
  • Carbamic acid, 2-hydroxy-3-(o-tolyloxy)propyl ester
  • EINECS 208-553-1
  • Kimavoxyl
  • MC 2303
  • Mephenesin carbamate
  • NSC 169508
  • SQ 2303
  • Tolseram
  • UNII-PAD6SXB23N

Systematic Names

  • 1,2-Propanediol, 3-(2-methylphenoxy)-, 1-carbamate (9CI)
  • 1,2-Propanediol, 3-(o-tolyloxy)-, 1-carbamate (8CI)
  • 2-Hydroxy-3-(o-tolyloxy)propyl carbamate
  • Carbamic acid, 2-hydroxy-3-(o-tolyloxy)propyl ester

Registry Numbers

CAS Registry Number

  • 533-06-2

FDA UNII

  • PAD6SXB23N

System Generated Number

  • 0000533062

Structure Descriptors

InChI

1S/C11H15NO4/c1-8-4-2-3-5-10(8)15-6-9(13)7-16-11(12)14/h2-5,9,13H,6-7H2,1H3,(H2,12,14)

InChIKey

KRPAJLYSLFNDOA-UHFFFAOYSA-N

Smiles

c1(c(cccc1)C)OC[C@@H](COC(N)=O)O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
hamster LD50 intraperitoneal 385mg/kg (385mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.
hamster LD50 oral 982mg/kg (982mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ATAXIA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.
mouse LD50 intraperitoneal 490mg/kg (490mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ATAXIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.
mouse LD50 oral 1050mg/kg (1050mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: ATAXIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.
rat LD50 intraperitoneal 413mg/kg (413mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: ATAXIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.
rat LD50 oral 1050mg/kg (1050mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.